103 related articles for article (PubMed ID: 23000435)
1. Liver transplantation for hepatocellular carcinoma in a patient with a novel telomerase mutation and steatosis.
Valenti L; Dongiovanni P; Maggioni M; Motta BM; Rametta R; Milano M; Fargion S; Reggiani P; Fracanzani AL
J Hepatol; 2013 Feb; 58(2):399-401. PubMed ID: 23000435
[TBL] [Abstract][Full Text] [Related]
2. Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States.
Afzali A; Berry K; Ioannou GN
Liver Transpl; 2012 Jan; 18(1):29-37. PubMed ID: 21932374
[TBL] [Abstract][Full Text] [Related]
3. Obesity, fatty liver and liver cancer.
Qian Y; Fan JG
Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):173-7. PubMed ID: 15908310
[TBL] [Abstract][Full Text] [Related]
4. Metabolic risk factors are a major comorbidity in patients with cirrhosis independent of the presence of hepatocellular carcinoma.
Hessheimer AJ; Forner A; Varela M; Bruix J
Eur J Gastroenterol Hepatol; 2010 Oct; 22(10):1239-44. PubMed ID: 20505515
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of hepatic iron overload and association with hepatocellular cancer in end-stage liver disease: results from the National Hemochromatosis Transplant Registry.
Ko C; Siddaiah N; Berger J; Gish R; Brandhagen D; Sterling RK; Cotler SJ; Fontana RJ; McCashland TM; Han SH; Gordon FD; Schilsky ML; Kowdley KV
Liver Int; 2007 Dec; 27(10):1394-401. PubMed ID: 17927713
[TBL] [Abstract][Full Text] [Related]
6. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.
Salomao M; Yu WM; Brown RS; Emond JC; Lefkowitch JH
Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341
[TBL] [Abstract][Full Text] [Related]
7. Liver transplantation in patients with nonalcoholic steatohepatitis-related hepatocellular carcinoma.
Malik SM; Gupte PA; de Vera ME; Ahmad J
Clin Gastroenterol Hepatol; 2009 Jul; 7(7):800-6. PubMed ID: 19281869
[TBL] [Abstract][Full Text] [Related]
8. NASH and HCC.
Page JM; Harrison SA
Clin Liver Dis; 2009 Nov; 13(4):631-47. PubMed ID: 19818310
[TBL] [Abstract][Full Text] [Related]
9. Patient with hepatitis B and alcoholic liver disease before and after liver transplantation.
Ward SC; Chang CY; Peng L; Liu LU
Semin Liver Dis; 2009 May; 29(2):233-7. PubMed ID: 19387922
[TBL] [Abstract][Full Text] [Related]
10. Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis.
Serfaty L; Lemoine M
Diabetes Metab; 2008 Dec; 34(6 Pt 2):634-7. PubMed ID: 19195623
[TBL] [Abstract][Full Text] [Related]
11. Comparison between human-telomerase reverse transcriptase mRNA and alpha-fetoprotein mRNA as a predictive value for recurrence of hepatocellular carcinoma in living donor liver transplantation.
Oya H; Sato Y; Yamamoto S; Nakatsuka H; Kobayashi T; Hara Y; Waguri N; Suda T; Aoyagi Y; Hatakeyama K
Transplant Proc; 2006 Dec; 38(10):3636-9. PubMed ID: 17175353
[TBL] [Abstract][Full Text] [Related]
12. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
13. Hepatic resection for hepatocellular carcinoma in elderly patients.
Yeh CN; Lee WC; Jeng LB; Chen MF
Hepatogastroenterology; 2004; 51(55):219-23. PubMed ID: 15011868
[TBL] [Abstract][Full Text] [Related]
14. General evaluation of hepatectomy and hepatocellular carcinoma cases.
Başsüllü N; Türkmen I; Yaprak O; Dayangaç M; Demırbaş T; Güler N; Uraz S; Akyildiz M; Cığercıoğullari E; Tokat Y; Yüzer Y; Doğusoy GB
Turk Patoloji Derg; 2011; 27(3):221-9. PubMed ID: 21935872
[TBL] [Abstract][Full Text] [Related]
15. Liver transplantation for hepatocellular carcinoma: the impact of human immunodeficiency virus infection--21 plus 13.
Baccarani U; Adani GL; Tavio M; Viale P
Hepatology; 2011 Jun; 53(6):2138; author reply 2138-9. PubMed ID: 21391221
[No Abstract] [Full Text] [Related]
16. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?
Adam R; Azoulay D; Castaing D; Eshkenazy R; Pascal G; Hashizume K; Samuel D; Bismuth H
Ann Surg; 2003 Oct; 238(4):508-18; discussion 518-9. PubMed ID: 14530722
[TBL] [Abstract][Full Text] [Related]
17. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States.
Marrero JA; Fontana RJ; Su GL; Conjeevaram HS; Emick DM; Lok AS
Hepatology; 2002 Dec; 36(6):1349-54. PubMed ID: 12447858
[TBL] [Abstract][Full Text] [Related]
18. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?
Nair S; Mason A; Eason J; Loss G; Perrillo RP
Hepatology; 2002 Jul; 36(1):150-5. PubMed ID: 12085359
[TBL] [Abstract][Full Text] [Related]
19. Hepatic, cardiovascular, and endocrine outcomes of the histological subphenotypes of nonalcoholic fatty liver disease.
Rubinstein E; Lavine JE; Schwimmer JB
Semin Liver Dis; 2008 Nov; 28(4):380-5. PubMed ID: 18956294
[TBL] [Abstract][Full Text] [Related]
20. [Hepatic resection and transplantation for hepatocellular carcinoma in patients with cirrhosis].
Gugenheim J; Baldini E; Casaccia M; Ouzan D; Saint-Paul MC; Mouiel J
Gastroenterol Clin Biol; 1997; 21(8-9):590-5. PubMed ID: 9587497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
